Researchers at the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences explored the regenerative mechanisms behind spinal cord injury (SCI) repair. By constructing ...

Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

NEW YORK - Tiziana Life Sciences Ltd. (NASDAQ:TLSA), a biotech firm focused on immunomodulation therapies with a market ...

Spinal cord injury (SCI) is characterized by the temporary or permanent loss of motion or sensation function caused by damage to the spinal cord. Among the mechanisms behind SCI, neuroinflammation is ...

Tiziana Life Sciences announces positive results from studies using nasal anti-CD3 mAb in traumatic spinal cord injury: New York Saturday, January 25, 2025, 13:00 Hrs [IST] Tizian ...

Tiziana Life Sciences Ltd., which is developing the intranasal fully human anti-CD3 monoclonal antibody foralumab for neurological indications, has reported results from studies using a nasal anti-CD3 ...

As ONWARD Medical’s US government contracting and logistics partner, Lovell will also collaborate with the Company to make the ARC-EX System available through the Defense Logistics Agency's Electronic ...

According to the team’s results, the BrainGate array wired directly to motor neurons offered a “sixfold improvement” on the ...

NervGen completed enrollment for its phase 2 trial in spinal cord injury ... process of glial scarring (for instance, due to injury like SCI), neuron’s axons — which relay signals — become ...